Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)

Blood

Volumn 113, Issue 6, 2009, Pages 1294-1303

  Grubor, Vladimir ^a   Krasnitz, Alex ^a   Troge, Jennifer E ^a   Meth, Jennifer L ^a   Lakshmi, B ^a   Kendall, Jude T ^a   Yamrom, Boris ^a   Alex, Garrick ^a   Pai, Deepa ^a   Navin, Nicholas ^a   Hufnagel, Lisa A ^a   Lee, Yoon Ha ^a   Cook, Kerry ^a   Allen, Steven L ^b,c   Rai, Kanti R ^b,d   Damle, Rajendra N ^b   Calissano, Carlo ^b   Chiorazzi, Nicholas ^b,c   Wigler, Michael ^a   Esposito, Diane ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b Feinstein Institute   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; DNA;

ARTICLE; B LYMPHOCYTE; CANCER RECURRENCE; CHRONIC LYMPHATIC LEUKEMIA; CLONE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENOMICS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME ABERRATION; CHROMOSOME MAP; CYTOLOGY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMIC INSTABILITY; HUMAN CHROMOSOME; HUMAN GENOME; KARYOTYPING; METABOLISM; METHODOLOGY; NEUTROPHIL; PROGNOSIS; TUMOR CELL CULTURE;

ANTIGENS, CD38; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR CELLS, CULTURED;

EID: 60849118132     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-05-158865     Document Type: Article

References (44)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-815.
2. American Cancer Society. Cancer Facts and Figures and CLL Detailed Guide. Atlanta, GA: American Cancer Society; 2008.
3. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46: 219-234.
4. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198-206.
5. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
7. Kröber A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410-1416.
8. Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 Compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351:893-901.
9. Gahrton G, Robert KH, Friberg K, Zech L, Bird AG. Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood. 1980;56: 640-647.
10. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood. 2006;108: 3152-3160.
11. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia. 2007;21:2442-2451.
12. Döhner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343: 1910-1916.
13. Xu W, Li JY, Pan JL, et al. Interphase fluorescence in situ hybridization detection of cytoge-netic abnormalities in B-cell chronic lymphocytic leukemia. Int J Hematol. 2007;85:430-436.
14. Bentz M, Huck K, du Manoir S, et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood. 1995;85:3610-3618.
15. Han T, Ozer H, Sadamori N, et al. Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. N Engl J Med. 1984;310:288-292.
16. Juliusson G, Robert KH, Ost A, et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocy-toma. Blood. 1985;65:134-141.
17. Lucito R, West J, Reiner A, et al. Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res. 2000;10:1726-1736.
18. Lucito R, Healy J, Alexander J, et al. Representational oligonucleotide microarray analysis: a highresolution method to detect genome copy number variation. Genome Res. 2003;13:2291-2305.
19. Fais F, Grotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
20. Hicks J, Krasnitz A, Lakshmi B, et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 2006;16:1465-1479.
21. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
22. Yang YH, Speed T. Design issues for cDNA mi-croarray experiments. Nat Rev Genet. 2002;3: 579-588.
23. Tseng GC, Oh M-K, Rohlin L, Liao JC, Wong WH. Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res. 2001;29:2549-2557.
24. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528.
25. Szczepanski T, Beishuizen A, Pongers-Willemse MJ, et al. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia. 1999;13: 196-205.
26. LeBien TW, Elstrom RL, Moseley M, Kersey JH, Griesinger F. Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells. Blood. 1990;76: 1196-1200.
27. Juliusson G, Oscier D, Juliusson G, et al. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leukemia Lymphoma. 1991;5:21-25.
28. Stilgenbauer S, Bullinger L, Benner A, et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia. 1999;13:1331-1334.
29. Cuneo A, Rigolin GM, Bigoni R, et al. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Leukemia. 2004;18:476-483.
30. Athanasiadou A, Stamatopoulos K, TsezouA, et al. Report of novel chromosomal abnormalities in a series of 130 chronic lymphocytic leukemia patients studied by classic cytogenetic analysis. Leuk Lymphoma. 2006;47:2084-2087.
31. Nelson BP, Gupta R, Dewald GW, Paternoster SF, Rosen ST, Peterson LC. Chronic Lymphocytic Leukemia FISH Panel: impact on diagnosis.Am J Clin Pathol. 2007;128:323-332.
32. Beà S, Lopez-Guillermo A, Ribas M, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol. 2002;161:957-968.
33. Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci U S A. 2004;101: 1039-1044.
34. Pfeifer D, Pantic M, Skatulla I, et al. Genomewide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood. 2007;109:1202-1210.
35. Tyybakinoja A, Vilpo J, Knuutila S. High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia. Cytogenet Genome Res. 2007;118:8-12.
36. Fernàndez V, Jares P, Salaverria I, et al. Gene expression profile and genomic changes in disease progression of early-stage chronic lympho-cytic leukemia. Haematologica. 2008;93:132-136.
37. Bernheim A, Dessen P, Lazar V, et al. Cryptic del(13q14.2) and physiological deletions of immunoglobulin genes detected by high-resolution array comparative genomic hybridization in a patient with indolent chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2007;176:89-91.
38. Patel A, Kang SH, Lennon PA, et al. Validation of a targeted DNA microarray for clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.Am J Hematol. 2008;83:540-546.
39. Ouillette P, Erba H, Kujawski L, Kaminski M, Shedden K, Malek SN. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res. 2008; 68:1012-1021.
40. Odero MD, Soto JL, Matutes E, et al. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL. Cancer Genet Cytogenet. 2001;130:8-13.
41. Tsukasaki K, Lohr D, Sugahara K, et al. Comparative genomic hybridization analysis of Japanese B-cell chronic lymphocytic leukemia: correlation with clinical course. Leuk Lymphoma. 2006; 47:261-266.
42. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949-951.
43. Damle RN, Temburni S, Calissano C, et al. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood. 2007;110:3352-3359.
44. Patten PEM, Buggins AGS, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood. 2008;111:5173-5181.